Patent
Issued
Title
Score
US05853723 12/29/1998
Targeting of peg antibody conjugates to islet cells
100%
US05843692 12/01/1998
Automatic initiation of a time interval for measuring glucose concentration in a sample of whole blood
100%
US05811266 09/22/1998
Methods for producing human insulin
100%
US05792656 08/11/1998
Methods of preparing genetically engineered cells that produce insulin in response to glucose
100%
US05783556 07/21/1998
Formulated insulin-containing composition
100%
US05747325 05/05/1998
Devices comprising genetically engineered .beta.cells
100%
US05744327 04/28/1998
Methods for producing insulin in response to non-glucose secretagogues
100%
US05728385 03/17/1998
Method and composition for an early vaccine to protect against both common infectious diseases and chronic immune mediated disorders or their sequelae
100%
US05762937 06/09/1998
Methods and compositions for the early detection and treatment of insulin dependent diabetes mellitus
99%
US05723283 03/03/1998
Method and composition for an early vaccine to protect against both common infectious diseases and chronic immune mediated disorders or their sequelae
99%
US05811242 09/22/1998
Marker and reagent for diabetes mellitus and diabetes mellitus complication
98%
US05843886 12/01/1998
Method of treating or preventing Type 1 diabetes by oral administration of insulin
97%
US05830434 11/03/1998
Methods of treating non-insulin dependent diabetes mellitus with pancreatic polypeptide
97%
US05803896 09/08/1998
Method and device for the treatment of diabetes mellitus
97%
US05801177 09/01/1998
Method for controlling and/or lowering serum glucose and fatty acid concentrations and hypertensive blood pressure in non-insulin-dependent diabetic patients
97%
US05730975 03/24/1998
Treatment of insulin resistance in obesity linked type II diabetes using antagonist to TNF-alpha function
97%
US05874454 02/23/1999
Use of thiazolidinedione derivatives in the treatment of polycystic ovary syndrome, gestational diabetes and disease states at risk for progressing to noninsulin-dependent diabetes mellitus
96%
US05869534 02/09/1999
Glycosylation of lipids and lipid-containing particles, and diagnostic and therapeutic methods and materials derived therefrom
96%
US05854067 12/29/1998
Hexokinase inhibitors
96%
US05837236 11/17/1998
Isolated porcine pancreatic cells for use in treatment of diseases characterized by insufficient insulin activity
96%
US05801200 09/01/1998
Methods and materials for the diagnosis and treatment of conditions such as stroke
96%
US05795726 08/18/1998
Methods for identifying compounds useful in treating type II diabetes
96%
US05780615 07/14/1998
Glycosylation of lipids and lipid-containing particles and diagnostic and therapeutic methods and materials derived therefrom
96%
US05733933 03/31/1998
Methods and materials for the diagnosis and treatment of conditions such as stroke
96%
US05733524 03/31/1998
Methods and materials for the diagnosis and treatment of conditions such as stroke
96%
US05718883 02/17/1998
Transgenic animal model for autoimmune diseases
96%
US05858968 01/12/1999
Method of treating or preventing type 1 diabetes by oral administration of insulin
95%
US05834422 11/10/1998
AspB28 insulin compositions
95%
US05827828 10/27/1998
Sulfated glycolipids and antibodies thereto for prophylaxis or therapy of diabetes
95%
US05800998 09/01/1998
Assays for diagnosing type II diabetes in a subject
95%
US05780021 07/14/1998
Method for treating type 1 diabetes using .alpha.-interferon and/or .beta.-i
95%
US05770381 06/23/1998
Methods for the diagnosis of diabetes and prediabetic conditions
95%
US05763396 06/09/1998
Method of treating or preventing type 1 diabetes by oral administration of insulin
95%
US05708012 01/13/1998
Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of insulin resistant subjects with normal glucose tolerance in order to prevent or delay the onset of noninsulin-dependent mellitus
95%
US05850840 12/22/1998
Methods for measurement and treatment predicated on the presence of advanced glycosylation endproducts in tobacco and its combustion byproducts
94%
US05869077 02/09/1999
Methods for treating diabetes by delivering insulin from biocompatible cell-containing devices
93%
US05846740 12/08/1998
Methods and kits useful for detecting autoantibody to glutamic acid decarboxylase
93%
US05830853 11/03/1998
Systemic administration of a therapeutic preparation
93%
US05814650 09/29/1998
Biotin amides able to control glucidic metabolisms under dysmetabolic conditions and relative therapeutical compositions
93%
US05773004 06/30/1998
Compositions for curing diabetes mellitus, processes for the preparation of same, and usage of same
93%
US05871769 02/16/1999
Methods and compositions for the prevention and treatment of diabetes mellitus
92%
US05840493 11/24/1998
Mitochondrial DNA mutations that segregate with late onset diabetes mellitus
92%
US05834308 11/10/1998
In vitro growth of functional islets of Langerhans
92%
US05804576 09/08/1998
Derivatives of 5-androsten-17-ones and 5-androstan-17-ones
92%
US05747445 05/05/1998
Therapeutic preparation for inhalation
92%
US05849506 12/15/1998
Reagents and methods for the diagnosis and treatment of diabetes and stiff man syndrome
91%
US05804590 09/08/1998
Treatment and prophylaxis of osteoporosis
91%
US05795861 08/18/1998
Methods for regulating gastrointestinal motility
91%
US05750348 05/12/1998
Method for detecting insulin resistance
91%
US05866578 02/02/1999
Substituted pyrimidines for control of diabetic complications
90%
US05859037 01/12/1999
Sulfonylurea-glitazone combinations for diabetes
90%
US05822715 10/13/1998
Diabetes management system and method for controlling blood glucose
90%
US05821334 10/13/1998
Insulin-dependent diabetes mellitus-specific chimeric polypeptides
90%
US05809477 09/15/1998
Method, apparatus and medium for allocating beds in a pediatric intensive care unit and for evaluating quality of care
90%
US05771891 06/30/1998
Apparatus and method for non-invasive blood analyte measurement
90%
US05766856 06/16/1998
Diagnostic method for evaluating advanced glycosylation endproducts using MAC-2 receptor
90%
US05766620 06/16/1998
Buccal delivery of glucagon-like insulinotropic peptides
90%
US05756461 05/26/1998
Methods for treating diabetes
90%
US05752512 05/19/1998
Apparatus and method for non-invasive blood analyte measurement
90%
US05747527 05/05/1998
Furanoeremophilane and eremophilanolide sesquiterpenes for treatment of diabetes
90%
US05741491 04/21/1998
Medicinal composition for diabetes
90%
US05725860 03/10/1998
Method for reducing the risk of developing diabetes
90%
US05871945 02/16/1999
Modulators of anchoring protein function
89%
US05866563 02/02/1999
Vanadium compositions
89%
US05866546 02/02/1999
Treatment for diabetes
89%
US05863555 01/26/1999
Buccal delivery of glucagon-like insulinotropic peptides
89%
US05851531 12/22/1998
Adult-onset diabetes treatment method
89%
US05849322 12/15/1998
Compositions and methods for buccal delivery of pharmaceutical agents
89%
US05840680 11/24/1998
ASPB28 insulin crystals
89%
US05827898 10/27/1998
Use of bisphenolic compounds to treat type II diabetes
89%
US05780034 07/14/1998
Diagnosis and treatment of insulin dependent diabetes mellitus using heat shock protein determinents
89%
US05766851 06/16/1998
Susceptibility gene for obesity and type II diabetes mellitus
89%
US05725854 03/10/1998
Methods of treating disease using sertoli cells an allografts or xenografts
89%
US05874099 02/23/1999
Methods for making immunoisolatary implantable vehicles with a biocompatible jacket and a biocompatible matrix core
88%
US05871767 02/16/1999
Methods for treatment or prevention of neurodegenerative conditions using immunoisolatory implantable vehicles with a biocompatible jacket and a biocompatible matrix core
88%
US05863724 01/26/1999
Methods of screening for persistent hyperinsulinemic hypoglycemia of infancy
88%
US05849584 12/15/1998
Cell cultures of and cells culturing method for nontransformed parotid cells
88%
US05834001 11/10/1998
Methods for making immunoisolatory implantable vehicles with a biocompatiable jacket and a biocompatible matrix core
88%
US05830895 11/03/1998
Methods for the determination and adjustment of prolactin daily rhythms
88%
US05824668 10/20/1998
Formulation for administration of steroid compounds
88%
US05817634 10/06/1998
Methods of treating diabetes mellitus and clycogen storage disease
88%
US05800829 09/01/1998
Methods for coextruding immunoisolatory implantable vehicles with a biocompatible jacket and a biocompatible matrix core
88%
US05800828 09/01/1998
Implantable biocompatible immunoisolatory vehicle for delivery of selected therapeutic products
88%
US05798113 08/25/1998
Implantable biocompatible immunoisolatory vehicle for delivery of selected therapeutic products
88%
US05795735 08/18/1998
Isolated polynucleotides encoding PKA-binding proteins and methods of producing the proteins recombinantly
88%
US05780299 07/14/1998
Method of altering blood sugar levels using non-transformed human pancreatic cells that have been expanded in culture
88%
US05733546 03/31/1998
Immunochemical detection of in vivo advanced glycosylation endproducts
88%
US05730654 03/24/1998
Multi-player video game for health education
88%
US05714479 02/03/1998
Endothelin antagonistic heteroaromatic ring-fused cyclopentene derivatives
88%
US05861266 01/19/1999
Treatment of diabetes mellitus and insulin receptor signal transduction
87%
US05858796 01/12/1999
Reagent and method for screening of the functional condition of the body
87%
US05849740 12/15/1998
Methods for using ketoconazole and related substances in medicaments for treatment of type II diabetes
87%
US05847004 12/08/1998
Method for in vivo reduction of nitric oxide levels and compositions useful therefor
87%
US05834032 11/10/1998
Compositions and methods for treating diabetes
87%
US05811075 09/22/1998
Method and agents for removing advanced glycosylation endproducts
87%
US05804411 09/08/1998
Polypeptide of protein P140 and DNAS encoding it
87%
US05798344 08/25/1998
Phosphonic ester derivatives of quinazolinones
87%
US05789652 08/04/1998
Non-insulin-dependent diabetic rat
87%
US05789401 08/04/1998
High-dose chromium/biotin treatment of type II diabetes
87%
US05786356 07/28/1998
Selective .beta.3 adrenergic agonists
87%
US05739106 04/14/1998
Appetite regulating compositions
87%
US05731292 03/24/1998
Dihydrochalcone derivatives which are hypoglycemic agents
87%
US05728704 03/17/1998
Substituted pyridmidines for control of diabetic complications
87%
US05712159 01/27/1998
Glucose responsive insulin secreting .beta.-cell lines and method for producing same
87%
US05871931 02/16/1999
Methods for detecting mammalian tub protein and RNA
85%
US05864018 01/26/1999
Antibodies to advanced glycosylation end-product receptor polypeptides and uses therefor
85%
US05861239 01/19/1999
Methods for identifying compounds that modulate mammalian tub protein activity
85%
US05849285 12/15/1998
Autoimmune disease treatment with sertoli cells and in vitro co-culture of mammal cells with sertoli cells
85%
US05843430 12/01/1998
Methods of treating disease using sertoli cells and allografts or xenografts
85%
US05824332 10/20/1998
Method and apparatus for treatment of neurogenic diabetes mellitus, and other conditions
85%
US05821125 10/13/1998
Monoclonal antibody specific for novel PKA binding proteins
85%
US05817762 10/06/1998
Mammalian tub protein
85%
US05814670 09/29/1998
Use of insulin sensitizing agents to treat hypertension
85%
US05767094 06/16/1998
Propiophenone derivative and processes for preparing the same
85%
US05763591 06/09/1998
Polynucleic acid sequences that are functionally associated with the development of autoimmune disease
85%
US05759534 06/02/1998
Methods of treating disease using sertoli cells and allografts or xenografts
85%
US05750345 05/12/1998
Detection of human .alpha.-thalassemia mutations and their use as predictors of blood-related disorders
85%
US05741776 04/21/1998
Method of administration of IGF-I
85%
US05741211 04/21/1998
System and method for continuous monitoring of diabetes-related blood constituents
85%
US05723476 03/03/1998
4-hydroxycoumarin-3-carboxamides for the treatment of diabetes mellitus
85%
US05716619 02/10/1998
Treatment of type 2 diabetes mellitus
85%
US05712101 01/27/1998
Immunochemical detection of in vivo advanced glycosylation endproducts
85%
US05705515 01/06/1998
Substituted sulfonamides as selective .beta.-3 agonists for the treatment of diabetes and obesity
85%
US05705483 01/06/1998
Glucagon-like insulinotropic peptides, compositions and methods
85%
US05871950 02/16/1999
Methods of treating autoimmune diseases and transplantation rejection
84%
US05866584 02/02/1999
Therapeutic process for the treatment of the pathologies of type II diabetes
84%
US05863903 01/26/1999
Use of hydroxy alkyl piperidine and pyrrolidine compounds to treat diabetes
84%
US05858977 01/12/1999
Method of treating diabetes mellitus using KGF
84%
US05858746 01/12/1999
Gels for encapsulation of biological materials
84%
US05858701 01/12/1999
DNA encoding an insulin receptor substrate
84%
US05849338 12/15/1998
Unit dosage forms for treatment of vasoconstriction and related conditions
84%
US05847008 12/08/1998
Method of treating diabetes and related disease states
84%
US05845254 12/01/1998
Method and apparatus for objectively monitoring and assessing the performance of health-care providers based on the severity of sickness episodes treated by the providers
84%
US05837812 11/17/1998
Human islet, human brain and mouse brain glutamic acid decarboxylase GAD polypeptides
84%
US05834428 11/10/1998
Glucagon-like peptide-2 and its therapeutic use
84%
US05833610 11/10/1998
Magnetic resonance imaging of cerebral blood flow and diagnosis of diabetes
84%
US05830999 11/03/1998
Stabilization of insulin through ligand binding interations
84%
US05827655 10/27/1998
Assay, methods and products based on n K
84%
US05807586 09/15/1998
Method of dietary supplementation
84%
US05801173 09/01/1998
Heterocyclic compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them
84%
US05786221 07/28/1998
Diagnostic test for measuring islet cell autoantibodies and reagents relating thereto
84%
US05770615 06/23/1998
Catecholamine surrogates useful as .beta.3 agonists
84%
US05767133 06/16/1998
Secondary amines as antidiabetic and antiobesity agents
84%
US05763478 06/09/1998
Triterpene derivatives with immunosuppressant activity
84%
US05763407 06/09/1998
High-purity desmopressin produced in large single batches
84%
US05756117 05/26/1998
Multidose transdermal drug delivery system
84%
US05747642 05/05/1998
Monomeric insulin analog formulations
84%
US05719022 02/17/1998
Process for diagnosing non-insulin-dependant diabetes mellitus
84%
US05714506 02/03/1998
Selective .beta.3 agonists for the treatment of diabetes and obesity
84%
US05710181 01/20/1998
Inhibition of nitric oxide formation in inflammatory bowel disease
84%
US05710145 01/20/1998
Protein kinase C inhibitor
84%
US05707641 01/13/1998
Formulations comprising therapeutically-active proteins or polypeptides
84%
USD0398341 09/15/1998
Stuffed toy for educating children with diabetes
84%
US05866555 02/02/1999
Diabetic supplement bar
83%
US05863715 01/26/1999
Methods for bulk cryopreservation encapsulated islets
83%
US05861485 01/19/1999
Polypeptides involved in body weight disorders, including obesity
83%
US05853975 12/29/1998
Methods for identifying compositions for the treatment of body weight disorders, including obesity
83%
US05852009 12/22/1998
Compositions, including pharmaceutical compositions, for inhibiting the advanced glycosylation of proteins, and therapeutic methods based thereon
83%
US05844102 12/01/1998
Glycohydrolase inhibitors, their preparation and use thereof
83%
US05843904 12/01/1998
Inhibitors of interleukin-1.beta.converting enzyme
83%
US05830873 11/03/1998
Propiophenone derivative and a process for preparing the same
83%
US05776685 07/07/1998
Protein kinase C assay
83%
US05756544 05/26/1998
Carboxyalkylethers, formulations, and treatment of vascular diseases
83%
US05719188 02/17/1998
Use of insulin sensitizing agents to treat hypertension
83%
US05719053 02/17/1998
Chromatographic method for the identification and characterization of hemoglobin variants in blood
83%
US05712265 01/27/1998
Administration of pirenzepine, methyl scopolamine and other muscarinin receptor antagonists for treatment of glucose metabolism disorders
83%
US05874231 02/23/1999
Methods of screening for non-hormone compounds which effect modulation of polypeptide translation
82%
US05874219 02/23/1999
Methods for concurrently processing multiple biological chip assays
82%
US05859051 01/12/1999
Antidiabetic agents
82%
US05858398 01/12/1999
Microparticular pharmaceutical compositions
82%
US05854272 12/29/1998
2-alkylpyrrolidines
82%
US05849293 12/15/1998
Use of human transferrin in controlling insulin levels
82%
US05846944 12/08/1998
Purified SDG as an antioxidant
82%
US05843788 12/01/1998
Chromatographic method for determination of glycated proteinaceous species in blood
82%
US05843652 12/01/1998
Isolation and characterization of Agouti: a diabetes/obesity related gene
82%
US05840738 11/24/1998
Selective .beta.-3 adrenergic agonists
82%
US05837727 11/17/1998
Method for altering blood lipid levels
82%
US05837255 11/17/1998
Method of reducing blood glucose by administering Harunganin or Vismin
82%
US05834454 11/10/1998
Substituted guanidine derivatives, process for production thereof, and pharmaceutical uses thereof
82%
US05830454 11/03/1998
Method for treating cell mediated autoimmune disorders using interleukin-9
82%
US05827513 10/27/1998
Methods of treating insulin-dependent diabetes mellitus by administration of IL-10
82%
US05821193 10/13/1998
Adsorbent having a terminal hydrazine group and a method for removing ketoamine-containing protein
82%
US05820570 10/13/1998
Interstitial fluid collection and constituent measurement
82%
US05817689 10/06/1998
Indole derivatives having a 2-phenyl-ethanolamino-substituted lower alkyl group at the 2-or 3-position thereof
82%
US05814654 09/29/1998
Substituted guanidine derivatives
82%
US05814647 09/29/1998
Use of troglitazone and related compounds for the treatment of the climacteric symptoms
82%
US05814600 09/29/1998
Method and composition for treatment of insulin requiring mammals
82%
US05808080 09/15/1998
Selective .beta.3 adrenergic agonists
82%
US05804421 09/08/1998
High level of expression of ingap in bacterial and euraryotic cells
82%
US05789651 08/04/1998
Isolation and characterization of Agouti: a diabetes/obesity related gene
82%
US05780490 07/14/1998
Oxime derivatives, their preparation and their therapeutic use
82%
US05776983 07/07/1998
Catecholamine surrogates useful as .beta.3 agonists
82%
US05773426 06/30/1998
Proteoglucan and antidiabetic drug thereof
82%
US05763392 06/09/1998
Treatment of diabetes by administration of myo-inositol
82%
US05760042 06/02/1998
Griseolic acid derivatives, their preparation and their use
82%
US05760001 06/02/1998
Cytokine restraining agents and methods of use in pathologies and conditions associated with altered cytokine levels
82%
USD0402369 12/08/1998
Housing for a device for measuring the concentration of an analyte in a sample of blood
82%
USD0399960 10/20/1998
Housing for a device for measuring the concentration of an analyte in a sample of blood
82%
USD0399959 10/20/1998
Housing for a device for measuring the concentration of an analyte in a sample of blood
82%
USD0399565 10/13/1998
Housing for a device for measuring the concentration of an analyte in a sample of blood
82%
